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ABSTRACT
A novel DNA strip assay, GenoType Mycobacter-
ium AS, was evaluated for its ability to identify
219 mycobacterial isolates in combination with
the GenoType Mycobacterium CM assay. The
results were compared with those obtained by
conventional 16S rDNA sequencing. The Geno-
type test correlated well (96%) with sequencing.
However, with the CM kit alone, it was possible
to identify most (88%) of the isolates found in
clinical specimens, and the AS kit provided very
little additional information.
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Non-tuberculous mycobacteria are isolated
increasingly from patient specimens in countries
where the incidence of tuberculosis is low [1], and
there is a need for rapid methods for their
identiﬁcation. Two DNA line probe assays,
INNO-LiPA Mycobacteria (Innogenetics, Ghent,
Belgium), targeting the 16S)23S rDNA spacer
region, and Genotype Mycobacterium common
mycobacteria (CM) (Hain Lifescience, Nehren,
Germany), targeting the 23S rDNA region, have
been developed for this purpose. These tests are
based on reverse hybridisation of PCR amplicons
to membrane-bound probes covering the species-
speciﬁc variable regions of the target genes. The
assays are reported to be sensitive (100%) and
speciﬁc (94.4–100%) for identiﬁcation of most
common mycobacteria [2–5].
The GenoType Mycobacterium additional spe-
cies (AS) kit supplements the CM kit and allows
identiﬁcation of 16 additional mycobacterial spe-
cies (Mycobacterium asiaticum, Mycobacterium cela-
tum,Mycobacteriumgastri,Mycobacteriumgenavense,
Mycobacterium goodii, Mycobacterium haemophilum,
Mycobacterium heckeshornense, Mycobacterium kans-
asii, Mycobacterium lentiﬂavum, Mycobacterium
mucogenicum, Mycobacterium phlei, Mycobacterium
shimoidei, Mycobacterium simiae, Mycobacterium
smegmatis, Mycobacterium szulgai ⁄Mycobacterium
intermedium and Mycobacterium ulcerans). This test
has been available in Europe since 2004, but an
evaluation from a clinical laboratory has not been
published previously. The aim of the present study
was to assess the usefulness of the GenoType
Mycobacterium CM and AS tests for the routine
identiﬁcation of mycobacteria isolated from
patient specimens in Finland.
All new patient isolates (n = 219) sent to the
Finnish Mycobacterial Reference Laboratory dur-
ing October–December 2004 were included in the
study. The isolates were received either on solid
Lo¨wenstein–Jensen media, or in BACTEC-MGIT
(BD Biosciences, Franklin Lakes, NJ, USA) or
MB ⁄BacT (bioMe´rieux, Marcy l’Etoile, France)
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liquid media. All isolates were identiﬁed by 16S
rDNA sequencing as described previously [4,6].
Mycobacterium chelonae and Mycobacterium absces-
sus were differentiated further by PCR–restriction
enzyme analysis of the hsp65 gene [7].
Bacteria were lysed by heating at 95C for
15 min, and the GenoType CM and AS assays
were performed according to the manufacturer’s
instructions. The protocols included methods for
PCR ampliﬁcation, hybridisation and detection,
and interpretation of the results. In addition to
species-speciﬁc probes, each test strip has a
conjugate control line to ensure that reactive
conjugate and substrate have been added, a
universal control probe that detects mycobacteria
and other Gram-positive bacteria with a high
G + C content, and a genus control line indicating
the presence of mycobacteria. Only bands with
intensities at least as strong as that of the
universal control were considered when interpre-
ting the results. All isolates were ﬁrst analysed
with the GenoType CM test strip. If the CM strip
result indicated Mycobacterium spp. or Mycobacte-
rium marinum ⁄M. ulcerans, the identiﬁcation
process was continued with the AS test strip.
The combination of the GenoType CM and AS
tests gave concordant results with 211 (96%) of
the 219 isolates when compared with the sequenc-
ing results (Table 1). Of the 219 isolates, three
were not mycobacteria, i.e., sequencing identiﬁed
Gordona sp., Actinomadura sp. and Kocuria sp.
These isolates were identiﬁed correctly as acid-
fast bacilli or were negative by the Genotype CM
kit. Of the eight isolates that gave discrepant
results, one Mycobacterium avium, one Mycobacte-
rium intracellulare and one Mycobacterium tubercu-
losis isolate were negative with the GenoType CM
test. The strips for these three isolates showed a
positive hybridisation pattern with the conjugate
control, but both the universal control and the
genus control were negative. Since the 16S rDNA
PCR and sequencing were successful when per-
formed from the same lysates, the GenoType PCR
and hybridisation tests were repeated, yielding
very faint universal control and genus control, as
well as species-speciﬁc, bands on the strips,
perhaps indicating that the ampliﬁcation reaction
with the GenoType primers was not efﬁcient.
Weak hybridisation caused by heterogeneity in
the probe-binding region is also a possibility.
Two isolates identiﬁed as M. intracellulare by
sequencing were identiﬁed as Mycobacterium
scrofulaceum by GenoType. These two species are
related closely, and the discrepancy may result
from the differences in the target gene regions
used by the two methods. In addition, two M.
kansasii isolates and one M. simiae isolate reacted
only with the genus probe, but not with the
species-speciﬁc probes. However, as stated in the
kit instructions, it is possible that certain subtypes
may not be detected because of the high variab-
ility of the bacterial genomes.
In total, 192 (88%) of the 219 isolates were
identiﬁed to the species level with the CM kit. This
is in agreement with reports published previously
[4,5]. M. marinum and M. ulcerans cannot be
differentiated by the CM kit, and therefore the
twoM. marinum ⁄M. ulcerans isolates, as well as the
19 isolates that reacted only with the genus probe,
were analysed further with the AS kit. Eight (38%)
of these 21 isolates (four M. lentiﬂavum, two M.
marinum and two M. simiae) were identiﬁed to the
species level with the AS test. No further identiﬁ-
cation was obtained for the remaining 11 isolates.
None of the isolateswere suspected originally to be
M. haemophilum, and thus they were not cultured
on speciﬁc blood media that would support the
Table 1. Comparison of identiﬁcation of Mycobacterium
spp. (acid-fast bacillus (AFB)-positive isolates) by DNA
sequencing, GenoType Mycobacterium (GT) common my-
cobacteria (CM) and additional species (AS) assays
Sequencing
result n
GT-CM and
AS correct GT incorrect
M. avium 43 42 1 negative
M. abscessus 2 2
M. bohemicum 3 3a
M. chelonae 3 3
M. fortuitum 9 9b
M. gordonae 23 23
M. intracellulare 28 25 1 negative; 2 M. scrofulaceum
M. interjectum 2 2
M. kansasii 2 0 2 Mycobacterium spp.
M. lentiﬂavum 4 4
M. malmoense 4 4
M. marinum 2 2
M. neoaurum 1 1a
M. nonchromogenicum 1 1a
M. peregrinum 1 1c
M. septicum 1 1c
M. simiae 3 2 1 Mycobacterium sp.
M. terrae 4 4a
M. tuberculosis 75 74 1 negative
M. xenopi 3 3
M. vaccae 1 1a
M. wolinskyi 1 1a
Gordona sp. 1 1 1 AFB
Actinomadura sp. 1 1 negative
Kocuria sp. 1 1 negative
Total 219 211 8
aCorrect GenoType result is Mycobacterium sp., since no species-speciﬁc probe is
available in the test strip.
bSeven isolates were positive with the M. fortuitum I probe, and one with the
M. fortuitum II probe.
cM. peregrinum, M. septicum and M. alvei cannot be differentiated by GT.
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growth of this species. Therefore, it was consid-
ered that an identiﬁcation as M. malmoense ⁄
M. haemophilum with the CM assay indicated the
presence of M. malmoense, although M. malmoense
andM. haemophilum could have been differentiated
further by the AS assay.
In Finland, one GenoType CM strip costs
25 Euros (September 2005), rising to a total cost
of 50 Euros if an additional AS strip is needed.
This is somewhat more expensive than sequenc-
ing (c. 20 Euros per reaction), but the GenoType
assay is faster and can be performed without any
expensive instrumentation.
In conclusion, the GenoType CM assay is a
rapid and reliable method for identiﬁcation of
mycobacteria in a clinical laboratory. Although
the additional information provided by the Geno-
Type AS assay is insufﬁcient to warrant its
uniform use, it is believed that laboratories
without sequencing facilities would beneﬁt from
the availability of this test.
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ABSTRACT
The distribution of ureC was investigated among
294 Escherichia coli isolates, comprising 72 strains
from the E. coli standard reference collection
(ECOR), 62 strains from the diarrhoeagenic E. coli
(DEC) collection, and 160 clinical isolates of Shiga
toxin-producing E. coli (STEC). The ureC gene was
more frequent among STEC isolates harbouring
eae than among those lacking eae (p < 0.0001). All
clinical STEC isolates of serogroups O111 and
O145 contained ureC, but only two of 294 isolates
expressed urease activity. The silencing of urease
expression could not be linked to a stop codon in
ureD. The frequent occurrence of ure genes in eae-
positive STEC isolates makes them valuable
markers for virulence.
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Shiga toxin-producing Escherichia coli (STEC)
strains cause diarrhoea, haemorrhagic colitis
and the haemolytic uraemic syndrome. STEC
strains associated with severe disease are also
termed enterohaemorrhagic E. coli (EHEC) in
order to differentiate them from STEC strains,
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